London: Pfizer recently achieved a significant legal victory by winning bid in a London court to invalidate two patents held ...

Pfizer Inc. ($PFE) has sold its stake worth $3.26 billion in UK-based consumer healthcare company Haleon PLC ($GB:HLN). With ...

GlaxoSmithKline would consider buying Pfizer’s consumer health business – but only if the price is right, according to the company's chief executive. Emma Walmsley has also been busy shaking ...

Maternal hepatitis C virus (HCV) infection is associated with a twofold increase in NICU admissions and nearly threefold increase in small-for-gestational-age births below the 5th percentile.

Dublin, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The "Adult Vaccine Market Report, Forecast by Disease, Countries and Company Analysis, 2024-2032" report has been added to ResearchAndMarkets.com's offering.

Dublin, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The "Adult Vaccine Market Report, Forecast by Disease, Countries and Company Analysis, 2024-2032" report has been added to ResearchAndMarkets.com's offering.

when Pfizer's patent expires in Sept (S) GlaxoSmithKline files lawsuit to block Teva Pharmaceutical Industries from selling generic version of Avandamet, Glaxo's diabetes drug; Teva is seeking ...

Clovis Oncology, Pfizer, and GlaxoSmithKline have also marketed rival PARP drugs, with the latter two making significant acquisitions – Medivation and Tesaro, respectively – to add the ...